期刊文献+

CK-20和LGALS4在甲状腺乳头状癌中的表达及临床意义 被引量:1

Expression of CK-20 and LGALS4 in papillary thyroid carcinoma and its clinical signifi-cance
下载PDF
导出
摘要 目的探讨角蛋白-20(cytokeratin-20,CK-20)和半乳糖凝集素4(galectin-4,LGALS4)在甲状腺乳头状癌中的表达及其临床意义。方法选取2010年1月-2014年6月在张家口市第一医院手术且经病理证实的甲状腺乳头状癌患者128例为研究对象,免疫组化检测癌组织及相应癌旁正常甲状腺组织CK-20、LGALS4的表达;ROC曲线分析CK-20、LGASL4对甲状腺乳头状癌的诊断价值;多因素Cox回归分析影响患者无病生存期(disease-free survival,DFS)的因素。结果甲状腺乳头状癌组织中CK-20阳性表达率高于癌旁正常组织,而LGALS4阳性表达率低于癌旁正常组织(均P<0.05);CK-20高表达、LGALS4低表达均与肿瘤远处转移、TNM分期、淋巴结转移有关(均P<0.05);CK-20与LGALS4表达水平呈负相关(r=-0.531,P<0.001);CK-20、LGALS4联合诊断甲状腺乳头状癌的曲线下面积、敏感度均优于其单独诊断(均P<0.05);CK-20阳性表达患者5年DFS低于阴性表达患者,而LGALS4阳性表达患者5年DFS高于阴性表达患者(均P<0.05);CK-20高表达、远处转移、淋巴结转移是DFS的独立危险因素,而LGALS4高表达是DFS的保护因素(均P<0.05)。结论甲状腺乳头状癌组织中CK-20与LGALS4表达呈负相关,CK-20高表达预示预后不良,而LGALS4高表达预示预后良好,两者有望成为监测甲状腺乳头状癌预后的生物标志分子。 Objective To investigate the expression of cytokeratin-20(CK-20)and galectin-4(LGALS4)in papillary thyroid carcinoma and its clinical significance.Methods A total 128 patients with pathologically confirmed papillary thyroid carcinoma who were operated in the First Hospital of Zhangjiakou from January 2010 to June 2014,were selected as the investigated subjects,from whom surgical cancer tissues and the corresponding adjacent normal tissues were collected.The expressions of CK-20 and LGALS4 was detected by immuno-histochemistry;the diagnostic value of CK-20 and LGASL4 in papillary thyroid carcinoma was analyzed by the ROC curve;the influence factors of disease-free survival(DFS)was analyzed by multivariable Cox regression.Results The positive expression rate of CK-20 in papillary thyroid carcinoma was higher than that in adjacent normal tissues,while the expression of LGALS4 was lower than that in adjacent normal tissues(all P<0.005).The high expression of CK-20 and low expression of LGALS4 were related to distant tumor metastasis,TNM stage,and lymph node metastasis(all P<0.05),and CK-20 expression was negatively correlated with LGALS4 expression level(r=-0.531,P<0.001).The area under the curve and sensitivity of the combined diagnosis of CK-20 and LGALS4 in thyroid papillary carcinoma was better than their single diagnosis(all P<0.05).The 5-year DFS of patients with CK-20 positive expression was lower than that of negative expression patients,while the 5-year DFS of LGALS4 positive expression patients was higher than that of negative expression patients(all P<0.05).The high expression of CK-20,distant metastasis and lymph node metastasis were independent risk factors for DFS,but high expression of LGALS4 was a protective factor for DFS(all P<0.05).Conclusions The expression of CK-20 and LGALS4 in papillary thyroid tissues is negatively correlated.High expression of CK-20 indicates a poor prognosis,while high expression of LGALS4 indicates a good prognosis,and both are expected to become biomarker molecules for monitoring the prognosis of papillary thyroid carcinoma.
作者 王志杰 栗晓东 田亮 张强 董路玲 宁建峰 霍占江 WANG Zhijie;LI Xiaodong;TIAN Liang;ZHANG Qiang;DONG Luling;NING Jianfeng;HUO Zhanjiang(Department of Otolaryngology Head and Neck Surgery,2Department of Endocrinology,3Department of Laboratory,First Hospital of Zhangjiakou,Zhangjiakou 075000,China)
出处 《中国癌症防治杂志》 CAS 2020年第3期341-346,共6页 CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
基金 张家口市重点研发计划项目(1921086D)。
关键词 甲状腺乳头状癌 角蛋白-20 半乳糖凝集素4 诊断 标志物 Papillary thyroid carcinoma Cytokeratin-20 Galectin-4 Diagnosis Biomarkers
  • 相关文献

参考文献7

二级参考文献75

  • 1Rabinovich GA, Llarrequi JM. Conveying glycan information into T- cell homeos-tatie programs:a challenging role for galectln-I in inflam- matory and tumor microenvi-ronments [ J ]. Immunol Rev, 2009,230 (1) :144-159.
  • 2Soumaoro LT, Uetake H, Hiquchi T, et al. Cyclooxygenase-2 expres- sion: a sigaifl-cant prognostic indicator for patients with colorectal cancer [ J ]. Clin Cancer Res,2004,10 (24) : 8465-8471.
  • 3Tsim NC, Frampton AE, Habib NA, et al. Surgical treatment for liver cancer[ J ]. World J Gastroentero1,2010,16 ( 8 ) :927-933.
  • 4Choi GH, Han Dtl, Kim DH, et al. Outcome after curative resection for a huge ( > or = 10cm) hepatoeellular carcinoma and prognostic signif- icance of gross tumor classification [ J ]. Am J Surg, 2009,198 ( 5 ) : 693-701.
  • 5Lee SG,Hwang S,Jung JP,et al. Outcome of patients with huge hepa- tocellular carcinoma after primary resection and treatment of recurrent lesions[J]. Br J Surg,2007,94(3) :320-326.
  • 6Tsuboi K, Shimura T, Masuda N, et at. Galectin-3 expression in color- ectal cancer:relation to invasion and metastasis[ J]. Anticancer Res, 2007,27 (4B) :2289-2296.
  • 7Kondoh N, Wakatsuki T, Ryo A, et al. Identification and characteriza- tion of genes associated with human hepatocellular carcinogenesis [ J ]. Cancer Res, 1999,59 ( 19 ) :4990-4996.
  • 8Roayaie S,Blume IN,Thung SN,et al. A system of classifying nficrovascu- lax invasion to predict outcome after resection in patients with hepatocd- lular carcinoma F J 1. Gastmentemloav .2009.137 ( 3 ) : 850 -855.
  • 9American Thyroid Association (ATA) Guidelines Taskforce on Thy- roid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American thyroid association manage- ment guidelines for patients with thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2009, 19(11):1167-1214.
  • 10Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid as- sociation management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid as- sociation guidelines task force on thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.

共引文献483

同被引文献7

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部